Aberrant activation of estrogen receptor‐α signaling in Mettl14‐deficient uteri impairs embryo implantation
The FASEB Journal · 2023
DOI: 10.1096/fj.202300735r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Ryosuke Kobayashi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genome Science, Biosignal Genome Resource Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan. Hauptthemen laut MEDLINE: Estrogen Receptor alpha, Receptors, Estrogen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development (AMED), MEXT, Japan Society for the Promotion of Science (JSPS).
Abstract (Originalsprache)
The precise control of endometrial receptivity is crucial for successful embryo implantation, which is strictly regulated by the ovarian steroid hormones estrogen and progesterone. Despite our improved understanding of the genetic regulation of implantation downstream of the action of hormones, we do not know much about the epigenetic regulation that occurs during early pregnancy. To investigate the role of the N6‐methyladenosine (m6A) RNA modification in embryo implantation, we generated mice with conditional deletion of Mettl14 , a core component of the m6A writer complex, in the uterus. These mice were infertile due to implantation failure. We showed that Mettl14 ‐deficient uteri had aberrant upregulation of estrogen receptor α (ERα) signaling and ERα phosphorylation, but progesterone receptor (PGR) signaling was largely unaffected. Additionally, Mettl14 deletion led to abnormal activation of the innate immune pathway in Mettl14 ‐deficient uteri. This effect was accompanied by the infiltration of immune cells, such as macrophages and dendritic cells, into the basal region of the endometrial epithelium. Methylated RNA immunoprecipitation sequencing (MeRIP‐seq) showed that genes involved in the innate immune response had decreased m6A peaks in Mettl14 ‐deficient mice. These results suggest that Mettl14 plays a crucial role in successful implantation by precisely regulating both ERα signaling and innate immunity in the uterus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Genome Science, Biosignal Genome Resource Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
- Division of Integrated Oncology Research, Gunma University Initiative for Advanced Research (GIAR), Gunma University, Maebashi, Japan.
- Graduate School of Veterinary Science, Azabu University, Sagamihara, Japan.
- Faculty of Veterinary Medicine, Kitasato University School of Veterinary Medicine, Aomori, Japan.
- Viral Vector Core, Gunma University Initiative for Advanced Research (GIAR), Maebashi, Japan.
ORCID-Profile: Reika Kawabata-Iwakawa
Förderung
- Japan Agency for Medical Research and Development (AMED)
- MEXT
- Japan Society for the Promotion of Science (JSPS)
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Kobayashi, R., Kawabata-Iwakawa, R., Terakawa, J., Sugiyama, M., Morita, S., Horii, T., & Hatada, I. (2023). Aberrant activation of estrogen receptor‐α signaling in Mettl14‐deficient uteri impairs embryo implantation. The FASEB Journal. https://doi.org/10.1096/fj.202300735r
Vancouver
Kobayashi R, Kawabata-Iwakawa R, Terakawa J, Sugiyama M, Morita S, Horii T, et al. Aberrant activation of estrogen receptor‐α signaling in Mettl14‐deficient uteri impairs embryo implantation. The FASEB Journal. 2023. doi:10.1096/fj.202300735r
BibTeX
@article{Kobayashi2023,
author = {Kobayashi, Ryosuke and Kawabata-Iwakawa, Reika and Terakawa, Jumpei and Sugiyama, Makoto and Morita, Sumiyo and Horii, Takuro and Hatada, Izuho},
title = {Aberrant activation of estrogen receptor‐α signaling in Mettl14‐deficient uteri impairs embryo implantation},
journal = {The FASEB Journal},
year = {2023},
doi = {10.1096/fj.202300735r}
}
EUVIMED